跳至主要内容
临床试验/NCT01198717
NCT01198717已完成不适用

Multicentre Paediatric Disease Registry in Essential Thrombocythaemia

Shire32 个研究点 分布在 8 个国家目标入组 60 人开始时间: 2010年9月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Shire
入组人数
60
试验地点
32
主要终点
Treatment effects on platelet count in children ages 6-17 years inclusive.

研究概览

简要总结

The aim of this study is to evaluate the progression of ET in children (aged 6-17years inclusive) over a period of 5 years maximum. The study will also assess how children are diagnosed, treatment options for those children with symptoms and events related to their ET and the outcomes of those treatments.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
6 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 6 years or over and less than 18 years patient has ET according to the WHO criteria as guidance

排除标准

  • Interventional clinical study participation

结局指标

主要结局

Treatment effects on platelet count in children ages 6-17 years inclusive.

时间窗: 60 months

次要结局

  • Drug utilization of cytoreductive therapy in children ages 6-17 years inclusive(60 months)

研究者

发起方
Shire
申办方类型
Industry
责任方
Sponsor

研究点 (32)

Loading locations...

相似试验